Document Detail


Genetic targeting of the renin-angiotensin system for long-term control of hypertension.
MedLine Citation:
PMID:  11790288     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although traditional approaches are effective for the treatment and control of hypertension, they have not succeeded in curing the disease, and have therefore reached a plateau. As a result of the completion of the Human Genome Project and the continuous advancement in gene delivery systems, it is now possible to investigate genetic means for the treatment and possible cure for hypertension. In this review we discuss the potential of genetic targeting of the renin-angiotensin system for the treatment of hypertension. We provide examples of various approaches that have used antisense technology with a high degree of success. We focus on our own research, which targets the use of antisense of the angiotensin type I receptor in various models of hypertension. Finally, we discuss the future of antisense technology in the treatment of human hypertension.
Authors:
Beverly L Metcalfe; Mohan Raizada; Michael J Katovich
Related Documents :
1552498 - Renin inhibitors containing alpha-heteroatom amino acids as p2 residues.
11087298 - Systolic hypertension, arterial stiffness, and vascular damage: role of the renin-angio...
8238548 - Adrenergic regulation of renin secretion and renal hemodynamics during deliberate hypot...
10962518 - Relationship between plasma renin profile and leptinaemia in patients with essential hy...
21845218 - Vascular stiffness and increased pulse pressure in the aging cardiovascular system.
20608558 - Perioperative management of obese patients.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current hypertension reports     Volume:  4     ISSN:  1522-6417     ISO Abbreviation:  Curr. Hypertens. Rep.     Publication Date:  2002 Feb 
Date Detail:
Created Date:  2002-01-15     Completed Date:  2002-04-10     Revised Date:  2006-07-12    
Medline Journal Info:
Nlm Unique ID:  100888982     Medline TA:  Curr Hypertens Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  25-31     Citation Subset:  IM    
Affiliation:
Department of Pharmacodynamics, University of Florida, College of Pharmacy, PO Box 100487, Gainesville, FL 32610-0487, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure / physiology
Forecasting
Gene Targeting
Gene Therapy*
Humans
Hypertension / genetics,  prevention & control,  therapy*
Myocardium / metabolism
Oligonucleotides, Antisense / therapeutic use*
Receptor, Angiotensin, Type 1
Receptors, Angiotensin / biosynthesis*
Renin-Angiotensin System / genetics*
Chemical
Reg. No./Substance:
0/Oligonucleotides, Antisense; 0/Receptor, Angiotensin, Type 1; 0/Receptors, Angiotensin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetics of the mineralocorticoid system in primary hypertension.
Next Document:  Cellular phenotypes and the genetics of hypertension.